Sensus Healthcare, Inc. (SRTS)
Automate Your Wheel Strategy on SRTS
With Tiblio's Option Bot, you can configure your own wheel strategy including SRTS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SRTS
- Rev/Share 2.4207
- Book/Share 3.2512
- PB 1.4825
- Debt/Equity 0.0123
- CurrentRatio 8.0589
- ROIC 0.0248
- MktCap 79264900.0
- FreeCF/Share 0.2842
- PFCF 17.0977
- PE 43.6566
- Debt/Assets 0.0109
- DivYield 0
- ROE 0.0334
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | SRTS | Lake Street | -- | Buy | -- | $18 | Jan. 31, 2025 |
News
Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?
Published: June 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Sensus Healthcare, Inc. (SRTS) Q1 2025 Earnings Call Transcript
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, IR Joe Sardano - Chairman and CEO Michael Sardano - President & General Counsel Javier Rampolla - Chief Financial Officer Conference Call Participants Yi Chen - H. C. Wainwright Jason Wittis - Roth Capital Jeremy Pearlman - Maxim Group Ben Haynor - Lake Street Capital Markets Operator Good day, and welcome to the Sensus Healthcare First Quarter 2025 Financial Results Conference Call.
Read More
Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.22, marking a -0.47% move from the previous day.
Read More
Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today
Published: March 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.78, moving +0.84% from the previous trading session.
Read More
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
About Sensus Healthcare, Inc. (SRTS)
- IPO Date 2016-07-26
- Website https://www.sensushealthcare.com
- Industry Medical - Devices
- CEO Mr. Joseph C. Sardano
- Employees 54